Crossmark

Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications

Crossref DOI link: https://doi.org/10.1039/C7CS00877E

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Spicer, Christopher D. https://orcid.org/0000-0001-8787-578X
Jumeaux, Coline https://orcid.org/0000-0002-6847-5331
Gupta, Bakul

Stevens, Molly M. https://orcid.org/0000-0002-7335-266X
Funding

Funding for this research was provided by:

Wellcome Trust (098411/Z/12/Z)

Stiftelsen för Strategisk Forskning (SSF 4-3713/2016)

Vetenskapsrådet (VR 4-478/2016)

Rosetrees Trust

GlaxoSmithKline (Imperial College London Engineered Medicines Labor)

FP7 Ideas: European Research Council (Naturale CG 616417)

Engineering and Physical Sciences Research Council (EP/K020641/1, EP/K031953/1)
License Information

Accepted Manuscript valid from 2019-02-26
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Christopher D. Spicer (ORCID)

: Coline Jumeaux (ORCID)

: Molly M. Stevens (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 16 December 2017; Advance Article published 26 February 2018; Version of Record published 21 May 2018